Disc Medicine (IRON) Non-Current Debt (2020 - 2026)
Disc Medicine's (IRON) quarterly Non-Current Debt came in at $29.4 million in Q1 2026, up 2.93% year-on-year from $28.5 million in Q1 2025, and up 0.71% on a QoQ basis from $29.2 million in Q4 2025.
Disc Medicine (IRON) Non-Current Debt (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 5 years of Non-Current Debt data on file, last reported at $29.4 million in Q1 2026.
- On a quarterly basis, Non-Current Debt rose 2.93% year-over-year to $29.4 million in Q1 2026; TTM through Mar 2026 was $29.4 million, a 2.93% increase from a year earlier, with the FY2025 full-year figure at $29.2 million, up 2.96% from the prior year.
- Non-Current Debt for Q1 2026 stood at $29.4 million, up from $29.2 million in the prior quarter.
- Over the last five years, Non-Current Debt for IRON reached as high as $29.4 million in Q1 2026 and fell as low as $28.3 million in Q4 2024.
- Historically, Non-Current Debt has averaged $28.8 million across 3 years, with a median of $28.8 million in 2025.
- Across the five-year window, Non-Current Debt advanced 2.96% in 2025 and climbed 2.93% in 2026, its largest moves.
- Year by year, Non-Current Debt stood at $28.3 million in 2024, then advanced by 2.96% to $29.2 million in 2025, then grew by 0.71% to $29.4 million in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $29.4 million in Q1 2026, $29.2 million in Q4 2025, and $28.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | 29.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.37 Mn |
| Dec 31, 2025 | 29.16 Mn |
| Sep 30, 2025 | 28.95 Mn |
| Jun 30, 2025 | 28.74 Mn |
| Mar 31, 2025 | 28.53 Mn |
| Dec 31, 2024 | 28.32 Mn |
| Dec 31, 2021 | 404,000.00 |
| Sep 30, 2021 | 1.65 Mn |
| Jun 30, 2021 | 2.89 Mn |
| Mar 31, 2021 | 4.13 Mn |
| Dec 31, 2020 | 4.95 Mn |